Financials data is unavailable for this security.
View more
Year on year Guangzhou LBP Medicine Science & Technology Co Ltd 's net income fell -6.18% from 42.69m to 40.06m despite relatively flat revenues. A contributing factor has been an increase in the percentage of sales devoted to the cost of goods sold from 29.04% to 32.35%.
| Gross margin | 66.92% |
|---|---|
| Net profit margin | 5.12% |
| Operating margin | 3.75% |
| Return on assets | 1.84% |
|---|---|
| Return on equity | 2.53% |
| Return on investment | 1.92% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Guangzhou LBP Medicine Science & Technology Co Ltd fell by 22.39m. However, the company earned 17.12m from its operations for a Cash Flow Margin of 3.44%. In addition the company used 32.70m on investing activities and also paid 6.89m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 13.62 |
|---|---|
| Tangible book value per share | 13.01 |
More ▼
Balance sheet in CNYView more
| Current ratio | 8.92 |
|---|---|
| Quick ratio | 7.74 |
| Total debt/total equity | 0.01 |
|---|---|
| Total debt/total capital | 0.0101 |
More ▼
Growth rates in CNY
Year on year, growth in dividends per share increased 7.14% while earnings per share excluding extraordinary items fell by -8.18%. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
| Div yield(5 year avg) | -- |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 43.73% |
| EPS growth(5 years) | -13.72 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -13.05 |
More ▼
